Loss of TRPV2 Homeostatic Control of Cell Proliferation Drives Tumor Progression

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• The Transient Receptor Potential Vanilloid channel family (TRPVs) includes TRPV2, a channel implicated in cellular processes.
• TRPV2 normally regulates cell proliferation and cell death upon activation.
• Dysregulation of TRPV2 signaling is observed in various cancer types.

Purpose of the Study:

• To investigate the role of TRPV2 channels in the development and progression of different tumors.
• To understand how TRPV2 function influences cancer cell behavior, including proliferation, apoptosis, and invasion.
• To explore the potential of TRPV2 as a therapeutic target in oncology.

Main Methods:

• Evaluation of TRPV2 channel involvement in tumor development and progression.
• Analysis of TRPV2 signaling pathways in normal and cancer cells.
• Assessment of TRPV2 expression and function in glioblastoma and prostate cancer models.
• Investigation of alternative splice variants of TRPV2 mRNA and their impact on channel function.

Main Results:

• Loss or inactivation of TRPV2 signaling leads to uncontrolled cell proliferation and resistance to apoptosis in some cancers (e.g., glioblastomas).
• In prostate cancer, TRPV2 activation by lysophospholipids enhances tumor cell invasion.
• TRPV2 expression increases during prostate cancer progression to castration resistance, correlating with metastatic disease.
• Alternative TRPV2 splice variants can inhibit wild-type TRPV2 channel function by preventing plasma membrane translocation.

Conclusions:

• TRPV2 channel activity has contrasting effects on cancer, promoting proliferation when lost but enhancing invasion when activated in specific contexts.
• Altered TRP channels, including TRPV2, are common in human cancers.
• Targeting TRP channels, such as TRPV2, shows promise for early cancer diagnosis and chemotherapy.